植入式心脏复律除颤器在预防心源性猝死中的应用：聚焦先天性心脏病和遗传性心律失常综合征
The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia Syndromes.
作者信息
Goldstein Sarah A, Ward Cary C, Al-Khatib Sana M
机构信息
Division of Cardiology, Duke University Hospital, Durham, NC, USA.
Duke Clinical Research Institute, Duke University Hospital, Durham, NC, USA.
出版信息
J Innov Card Rhythm Manag. 2018 Jan 15;9(1):2996-3005. doi: 10.19102/icrm.2018.090103. eCollection 2018 Jan.
Abstract
Some congenital heart diseases (CHDs) and inherited arrhythmia syndromes are associated with an increased risk of sudden cardiac death (SCD). Appropriate selection criteria for implantable cardioverter-defibrillator (ICD) implantation in these patients are poorly defined due to a paucity of data available from randomized clinical trials, leading to current guidelines relying more on non-randomized studies and expert opinions to make their recommendations. This review describes available evidence-based risk stratification methods for identifying patients at risk for SCD, as well as current guideline-driven management strategies for the use of ICDs in patients with CHD and inherited arrhythmia syndromes.
摘要
一些先天性心脏病（CHD）和遗传性心律失常综合征与心源性猝死（SCD）风险增加相关。由于缺乏来自随机临床试验的数据，这些患者植入式心律转复除颤器（ICD）植入的合适选择标准定义不清，导致当前指南更多地依赖非随机研究和专家意见来提出建议。本综述描述了用于识别SCD风险患者的现有循证风险分层方法，以及当前指南驱动的CHD和遗传性心律失常综合征患者使用ICD的管理策略。
相似文献
1
The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia Syndromes.植入式心脏复律除颤器在预防心源性猝死中的应用：聚焦先天性心脏病和遗传性心律失常综合征
J Innov Card Rhythm Manag. 2018 Jan 15;9(1):2996-3005. doi: 10.19102/icrm.2018.090103. eCollection 2018 Jan.
2
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层：可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
3
Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.小儿患者的心源性猝死与植入式心脏复律除颤器的应用。小儿电生理学会。
Circulation. 1993 Mar;87(3):800-7. doi: 10.1161/01.cir.87.3.800.
4
Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.心脏性猝死的预防：聚焦皮下植入式心律转复除颤器
High Blood Press Cardiovasc Prev. 2020 Aug;27(4):291-297. doi: 10.1007/s40292-020-00394-x. Epub 2020 Jun 9.
5
Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications.可植入式心律转复除颤器对遗传性心律失常综合征年轻患者的危害：不适当电击和并发症的系统评价和荟萃分析。
Heart Rhythm. 2016 Feb;13(2):443-54. doi: 10.1016/j.hrthm.2015.09.010. Epub 2015 Sep 15.
6
Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.通过评估植入式心脏复律除颤器患者的整体电不均一性心电图指标及临床结局来改善心脏性猝死风险分层：一项回顾性、多中心、队列研究的原理与设计
J Interv Card Electrophysiol. 2018 Jun;52(1):77-89. doi: 10.1007/s10840-018-0342-2. Epub 2018 Mar 14.
7
Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada.加拿大植入式心脏复律除颤器与胺碘酮用于心源性猝死一级预防的成本效益分析。
Curr Med Res Opin. 2009 Mar;25(3):617-26. doi: 10.1185/03007990802695037.
8
Patient Outcomes From a Specialized Inherited Arrhythmia Clinic.从专门的遗传性心律失常诊所获得的患者结果。
Circ Arrhythm Electrophysiol. 2016 Jan;9(1):e003440. doi: 10.1161/CIRCEP.115.003440.
9
Implantable defibrillators versus medical therapy for cardiac channelopathies.植入式除颤器与心脏离子通道病的药物治疗对比
Cochrane Database Syst Rev. 2015 Oct 7;2015(10):CD011168. doi: 10.1002/14651858.CD011168.pub2.
10
Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2017 年 AHA/ACC/HRS 室性心律失常患者管理和心源性猝死预防指南的系统评价：美国心脏病学会/美国心脏协会实践指南工作组和心律学会的报告。
J Am Coll Cardiol. 2018 Oct 2;72(14):1653-1676. doi: 10.1016/j.jacc.2017.10.052. Epub 2017 Oct 30.
引用本文的文献
1
Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective.1型强直性肌营养不良的多系统症状：管理与治疗视角
Int J Mol Sci. 2025 Jun 2;26(11):5350. doi: 10.3390/ijms26115350.
2
Identifying genomic variant associated with long QT syndrome type 2 in an ecuadorian mestizo individual: a case report.在一名厄瓜多尔混血个体中鉴定与2型长QT综合征相关的基因组变异：病例报告。
Front Genet. 2024 Jun 18;15:1395012. doi: 10.3389/fgene.2024.1395012. eCollection 2024.
3
Management of Implantable Cardioverter-Defibrillators during Pregnancy-A Systematic Review.孕期植入式心脏复律除颤器的管理——一项系统评价
J Clin Med. 2021 Apr 14;10(8):1675. doi: 10.3390/jcm10081675.
本文引用的文献
1
Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial.单腔除颤器中的长检测编程可减少不必要的治疗和死亡率：ADVANCE III 试验。
JACC Clin Electrophysiol. 2017 Nov;3(11):1275-1282. doi: 10.1016/j.jacep.2017.05.001. Epub 2017 May 31.
2
Sudden Cardiac Death in Adult Congenital Heart Disease.成人先天性心脏病中的心脏性猝死
Card Electrophysiol Clin. 2017 Jun;9(2):225-234. doi: 10.1016/j.ccep.2017.02.003. Epub 2017 Mar 18.
3
Ventricular Arrhythmias in Adult Congenital Heart Disease: Mechanisms, Diagnosis, and Clinical Aspects.成人先天性心脏病中的室性心律失常：机制、诊断与临床方面
Card Electrophysiol Clin. 2017 Jun;9(2):213-223. doi: 10.1016/j.ccep.2017.02.004. Epub 2017 Mar 18.
4
Factors associated with long-term mortality after Fontan procedures: a systematic review.Fontan手术后长期死亡率的相关因素：一项系统评价
Heart. 2017 Jan 15;103(2):104-110. doi: 10.1136/heartjnl-2016-310108. Epub 2016 Nov 9.
5
Sudden cardiac death in transposition of the great arteries with a Mustard or Senning baffle: the myocardial ischemia hypothesis.采用Mustard或Senning分流板的大动脉转位患者的心脏性猝死：心肌缺血假说
Curr Opin Cardiol. 2017 Jan;32(1):101-107. doi: 10.1097/HCO.0000000000000353.
6
Recent advances in genetic testing and counseling for inherited arrhythmias.遗传性心律失常的基因检测与咨询的最新进展
J Arrhythm. 2016 Oct;32(5):389-397. doi: 10.1016/j.joa.2015.12.009. Epub 2016 Feb 5.
7
Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease.成人先天性心脏病患者皮下植入式心律转复除颤器的临床经验
Circ Arrhythm Electrophysiol. 2016 Sep;9(9). doi: 10.1161/CIRCEP.116.004338.
8
Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.成人先天性心脏病患者植入式心脏复律除颤器的长期随访：适应证与结局
Europace. 2017 Mar 1;19(3):407-413. doi: 10.1093/europace/euw076.
9
Cause of death in adults with congenital heart disease - An analysis of the German National Register for Congenital Heart Defects.成人先天性心脏病的死因——德国先天性心脏缺陷国家登记册分析
Int J Cardiol. 2016 May 15;211:31-6. doi: 10.1016/j.ijcard.2016.02.133. Epub 2016 Mar 2.
10
Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis.先天性心脏病成人患者植入式心脏复律除颤器：一项系统评价和荟萃分析。
Eur Heart J. 2016 May 7;37(18):1439-48. doi: 10.1093/eurheartj/ehv735. Epub 2016 Feb 11.
Zotero 插件